Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from NKGen Biotech ( (NKGN) ) is now available.
On September 25, 2025, NKGen Biotech, Inc. announced a consulting agreement with Yong Man Kim, effective from September 10, 2025. Dr. Kim, who has transitioned from an employee to an independent contractor, will continue as the Chief Scientific Officer while also serving as President of NKMax. This arrangement allows NKGen Biotech to retain Dr. Kim’s expertise, supporting its research and development initiatives.
More about NKGen Biotech
Average Trading Volume: 63,066
Technical Sentiment Signal: Sell
Current Market Cap: $4.94M
For an in-depth examination of NKGN stock, go to TipRanks’ Overview page.